IP Library Granted Patent US 6,858,220
Granted Patent B2
US 6,858,220 · App. 10/046,458 · Granted Feb 22, 2005

Implantable microfluidic delivery system using ultra-nanocrystalline diamond coating

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,858,220
App. No.
10/046,458
Granted
Feb 22, 2005
Kind
B2
Abstract

An implantable biocompatible microchip drug delivery substrate is coated with a thin film of ultra-nanocrystalline diamond; assuring that the device is biocompatible and impermeably sealed, to prevent the substrate from being dissolved by the living tissue and to protect the drugs from premature release or undesired reaction with the body fluids. The coating is selectively patterned by doping to create electrically conductive areas that can be used as an electrically activated release mechanism for drug delivery. The conformal ultra-nanocrystalline diamond coating uniformly covers the device, providing relief from sharp edges and producing a strong, uniformly thick impermeable coating around sharp edges and on high aspect-ratio parts. The ultra-nanocrystalline diamond coating provides a conformal coating on the biocompatible device, which is of approximately uniform thickness around sharp corners and on high aspect-ratio parts. The conformal nature of the coating assures impermeability and strength despite the presence of difficult to coat shapes.

Claims (55)

1. A microfluidic delivery system for the transport of molecules comprising:

a substrate;

a reservoir in said substrate for containing the molecules;

a fluid control device controlling release of said molecules from said reservoir; and

a thin film inert impermeable coating applied to said substrate.

2. The microfluidic delivery system according to claim 1 wherein—said thin film inert impermeable coating is biocompatible.

3. The microfluidic delivery system according to claim 1 wherein—the molecules are comprised of drugs.

4. The microfluidic delivery system according to claim 1 wherein—said thin film inert impermeable coating is comprised of ultra-nanocrystalline diamond.

5. The microfluidic delivery system according to claim 1 wherein—said thin film inert impermeable coating is comprised of ceramic.

6. The microfluidic delivery system according to claim 5 wherein—said thin film inert impermeable coating is applied by ion-beam assisted deposition.

7. The microfluidic delivery system according to claim 5 wherein—said ceramic is comprised of alumina.

8. The microfluidic delivery system according to claim 5 wherein—said ceramic is comprised of zirconia.

9. The microfluidic delivery system according to claim 1 wherein—said fluid control device is a permeable cap.

10. The microfluidic delivery system according to claim 1 wherein

said fluid control device is a disintegrating cap.

11. The microfluidic delivery system according to claim 9 wherein

said cap is comprised of electrically conductive ultra-nanocrystalline diamond.

12. The microfluidic delivery system according to claim 1 wherein

said fluid control device is a pump.

13. The microfluidic delivery system according to claim 12 wherein

said pump is an electrostatic pump.

14. The microfluidic delivery system according to claim 12 wherein

said pump is an electromagnetic pump.

15. The microfluidic delivery system according to claim 12 wherein

said pump is a pneumatic pump.

16. The microfluidic delivery system according to claim 12 wherein

said pump is a piezoelectric pump.

17. The microfluidic delivery system according to claim 1 wherein

said fluid control device is a valve.

18. The microfluidic delivery system according to claim 17 wherein

said valve is an electrostatic valve.

19. The microfluidic delivery system according to claim 17 wherein

said valve is an electromagnetic valve.

20. The microfluidic delivery system according to claim 17 wherein

said valve is a pneumatic valve.

21. The microfluidic delivery system according to claim 17 wherein

said valve is a piezoelectric valve.

22. The microfluidic delivery system according to claim 1 wherein

said substrate is comprised of silicon.

23. A microfluidic delivery system for the release of molecules comprising:

a substrate;

at least one reservoir in the substrate that is suitable to contain the molecules;

the reservoir having a reservoir cap positioned on the reservoir over the molecules;

wherein release of the molecules from the reservoir is controlled by said reservoir cap; and wherein

wherein said substrate is coated with a thin film of ultra-nanocrystalline diamond deposited on said biocompatible device wherein said thin film forms a biocompatible impermeably sealed substrate.

24. The microfluidic delivery system according to claim 23 wherein

said molecules are released by diffusion through said reservoir cap.

25. The microfluidic delivery system according to claim 23 wherein

said molecules are released by disintegration of said reservoir cap.

26. The microfluidic delivery system according to claim 23 wherein

said substrate is comprised of silicon.

27. The microfluidic delivery system according to claim 23 wherein

said reservoir cap is comprised of a thin film of ultra-nanocrystalline diamond.

28. The microfluidic delivery system according to claim 27 wherein

at least a portion of said ultra-nanocrystalline diamond thin film is electrically conductive.

Assignments (2)
MERGER Recorded Jan 9, 2006
From: SECOND SITGHT, LLC
To: SECOND SIGHT MEDICAL PRODUCTS, INC.
Reel/Frame 017435/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2001
From: GREENBERG, ROBERT J.; MECH, BRIAN V.
To: SECOND SIGHT, LLC
Reel/Frame 012499/0955 →